@inproceedings{23c7b2b9465b41e8b980f0db09fa25d6,
title = "In vitro experimentation elucidates mechanisms of reported wound healing clinical outcomes using amnion-derived fluid and membrane products",
abstract = "Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell derived regenerative fluid product and an amniotic membrane product that are used to promote healing and repair. These products are used in a variety of treatments such as full and partial-thickness wounds, chronic wounds, and burns. Axolotl Ambient{\texttrademark} (fluid) and Axolotl Graft{\texttrademark} (membrane), have demonstrated efficacy closing complicated, chronic wounds. In vitro bioassays are being used to elucidate mechanisms of action that may help to explain these clinical results.",
author = "Dominic Dominguez and Audet, \{Robert G.\} and Diller, \{Robert B.\} and Tatum Bardsley and Kellar, \{Robert S\}",
note = "Publisher Copyright: {\textcopyright} 2019 Omnipress - All rights reserved.; 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence ; Conference date: 03-04-2019 Through 06-04-2019",
year = "2019",
language = "English (US)",
series = "Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium",
publisher = "Society for Biomaterials",
pages = "738",
booktitle = "Society for Biomaterials Annual Meeting and Exposition 2019",
}